Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

(NY: ENOV )

43.03 +0.60 (+1.41%)
Official Closing Price Updated: 7:00 PM EST, Nov 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,022,673
Open 42.51
Bid (Size) 42.06 (1)
Ask (Size) 43.99 (1)
Prev. Close 42.43
Today's Range 42.51 - 43.67
52wk Range 38.27 - 65.03
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Enovis to Host Third Quarter 2024 Results Conference Call on November 6th
From Enovis Corporation
Via GlobeNewswire
Orthopedic Implant Player Enovis' M&A Strategy Core To Growth And Competitiveness, Analyst Says
JMP Securities initiates coverage on Enovis Corporation with a Market Outperform rating, highlighting its strategic acquisitions, including LimaCorporate, and future growth potential. The analyst notes... 
Via Benzinga

Performance

YTD
-22.38%
-22.38%
1 Month
+8.61%
+8.61%
3 Month
+3.21%
+3.21%
6 Month
-15.49%
-15.49%
1 Year
-7.18%
-7.18%

More News

Read More
The Latest Analyst Ratings For Enovis
Via Benzinga
Enovis Appoints Tim Czartoski as President, U.S. Surgical and Global Product and Enabling Technologies
From Enovis Corporation
Via GlobeNewswire
Critical Insights From Enovis Analyst Ratings: What You Need To Know
Via Benzinga
A Closer Look at 6 Analyst Recommendations For Enovis
Via Benzinga
Enovis™ Introduces the Next Generation of Foot and Ankle Surgery Offerings at AOFAS Annual Meeting
From Enovis Corporation
Via GlobeNewswire
Enovis Continues to Redefine Revision Knee Surgery with the Addition of EMPOWR™ Cones to EMPOWR Revision Knee™, Creating a Comprehensive Portfolio for Efficient Revision Procedures
From Enovis Corporation
Via GlobeNewswire
Enovis™ Introduces STAR® Ankle, now with e+™ Polyethylene for Unmatched Durability
From Enovis Corporation
Via GlobeNewswire
Enovis to Participate in Upcoming Investor Conferences
From Enovis Corporation
Via GlobeNewswire
ENOV Stock Earnings: Enovis Beats EPS, Misses Revenue for Q2 2024
Via InvestorPlace
Enovis Announces Second Quarter 2024 Results
From Enovis Corporation
Via GlobeNewswire
Enovis Announces Time Change for Second Quarter 2024 Results Conference Call
From Enovis Corporation
Via GlobeNewswire
Enovis to Host Second Quarter 2024 Results Conference Call on August 7th
From Enovis Corporation
Via GlobeNewswire
Enovis™ Releases AltiVate Reverse® Glenoid System, Widening Range of Patients Who May be Treated with AltiVate Reverse®
From Enovis Corporation
Via GlobeNewswire
Top 3 Health Care Stocks That Could Blast Off In June
Via Benzinga
5 Medical Info Systems Stocks To Buy For Stable Returns
Via Talk Markets
Enovis to Participate in Upcoming Investor Conferences
From Enovis Corporation
Via GlobeNewswire
Top 4 Health Care Stocks Which Could Rescue Your Portfolio This Month
Via Benzinga
ENOV Stock Earnings: Enovis Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Enovis Announces First Quarter 2024 Results
From Enovis Corporation
Via GlobeNewswire
Enovis to Host First Quarter 2024 Results Conference Call on May 2nd
From Enovis Corporation
Via GlobeNewswire
Enovis to Participate in the 23rd Annual Needham Virtual Healthcare Conference
From Enovis Corporation
Via GlobeNewswire
Medtech Firm Enovis Sets Strong 2024 Targets As Q4 Earnings Beat Expectations, Analyst Says Growth Intact
Via Benzinga
Topics Earnings
Exposures Financial
Enovis Announces Fourth Quarter and Full Year 2023 Results
From Enovis Corporation
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.